Revenue and gross profit data for QQ3 2024 are not disclosed in the provided dataset. The company reports a gross profit line as null and a gross margin as null for QQ3 2024. The quarterly metrics that are available and relevant are:
- Operating Income: -$40,220; YoY change: +89.76%; QoQ change: +69.41%
- Net Income: -$99,470; YoY change: +77.99%; QoQ change: +42.59%
- EBITDA: $1,878; EBITDA metric implies a small positive operating margin on an adjusted basis, but the underlying operating loss and high interest burden override EBITDA as a true profitability signal in the period.
- Interest Expense: $101,348; Depreciation & Amortization: $40.22; Tax expense: -$40.22 (tax benefit reported).
- Earnings Per Share (EPS): -$0.0126; Diluted EPS: -$0.0126; Weighted average shares outstanding: 7,909,883.
- Cash flow: Net cash from operating activities: -$8,839; Change in working capital: $90,630; Accounts receivable: -$27,102; Accounts payable: $12,633; Other working capital: $117,732; Other non-cash: $27,103; Net cash used in operating activities: -$8,839; Net cash used for investing activities: -$15,000; Net cash provided by financing activities: $23,500; Net change in cash: -$340; Cash at end of period: $58; Cash at beginning of period: $398.
- Balance sheet (selected): Total assets $1,713,303; Total liabilities $4,225,583; Total stockholders’ equity $(2,512,280); Total debt $3,220,501; Net debt $3,220,443; Current ratio 0.453; Quick ratio 0.453; Cash ratio ~0.0000153; Total current liabilities $3,783,332; Long-term debt $442,251.
- Leverage and capital structure: Debt ratio 1.880; Debt-to-capitalization 4.55; Enterprise value multiple 4,031.35 (as reported); Price-to-book and price-to-earnings multiples are not favorable given negative equity and negative earnings. Note that several ratios are distorted by the negative stockholders’ equity, limiting meaningful interpretation of some traditional liquidity and solvency measures.